News | October 17, 2007

Hologic Improves Radiation Therapy, Reduces Hospital Stay

Hologic will demonstrate MammoSite, a targeted radiation therapy solution that works from the inside, meaning that a higher daily dose can be used for a shorter period of time, five days versus five to seven weeks. MammoSite places the radiation source inside the lumpectomy cavity, delivering radiation to the area where cancer is most likely to recur. The therapy is given on an outpatient basis. No hospital stay is required.

The company will also highlight new features of the Selenia S digital mammography system, a product specifically designed for the screening mammography facility or mobile environment. Selenia S uses the Hologic direct conversion detector, eliminating the need to convert X-rays to light, producing a sharp digital image reportedly with better contrast and detail.

The new tungsten X-ray tube option for Selenia is a tungsten tube in combination with a special silver filter and allows images to be acquired at a lower dose without compromising the superb image quality of Selenia. The silver filter’s intended use is for imaging thicker breasts with both lower dose and shorter exposure times to eliminate problems with patient motion.

Hologic is reportedly the first company to introduce the use of the silver filter with a tungsten tube in digital mammography. Systems shipped with the tungsten tube option will be calibrated to have a minimum of 30 percent reduction in dose, for a 4.5-centimeter breast, compared to Selenia/Molybdenum systems. Users have the option of choosing even lower dose settings, based on individual site preferences.

Company website: www.hologic.com

Related Content

Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...